| Literature DB >> 16494751 |
Simaly Phongmany1, Jean-Marc Rolain, Rattanaphone Phetsouvanh, Stuart D Blacksell, Vimone Soukkhaseum, Bouachanh Rasachack, Khamphong Phiasakha, Surn Soukkhaseum, Khamthavi Frichithavong, Vang Chu, Valy Keolouangkhot, Bertrand Martinez-Aussel, Ko Chang, Chirapha Darasavath, Oudayvone Rattanavong, Siho Sisouphone, Mayfong Mayxay, Sisouphane Vidamaly, Philippe Parola, Changpeng Thammavong, Mayboun Heuangvongsy, Bounkong Syhavong, Didier Raoult, Nicholas J White, Paul N Newton.
Abstract
Rickettsial diseases have not been described previously from Laos, but in a prospective study, acute rickettsial infection was identified as the cause of fever in 115 (27%) of 427 adults with negative blood cultures admitted to Mahosot Hospital in Vientiane, Laos. The organisms identified by serologic analysis were Orientia tsutsugamushi (14.8%), Rickettsia typhi (9.6%), and spotted fever group rickettsia (2.6% [8 R. helvetica, 1 R. felis, 1 R. conorii subsp. indica, and 1 Rickettsia "AT1"]). Patients with murine typhus had a lower frequency of peripheral lymphadenopathy than those with scrub typhus (3% vs. 46%, p<0.001). Rickettsioses are an underrecognized cause of undifferentiated febrile illnesses among adults in Laos. This finding has implications for the local empiric treatment of fever.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16494751 PMCID: PMC3373100 DOI: 10.3201/eid1202.050900
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Admission clinical features of 104 Lao adults with serologic evidence of acute murine and scrub typhus*
| Variable | Murine typhus (n = 41)† | Scrub typhus (n = 63)† | p value | Reference range |
|---|---|---|---|---|
| Age, (y)‡ | 40 (17–70) | 31 (16–73) | 0.5 | |
| No. (%) male | 26 (63) | 40 (63) | 0.6 | |
| No. days ill‡ | 11 (3–30) | 10 (2–42) | 0.2 | |
| Headache (%) | 38 (95) (n = 40) | 60 (95) | 1.0 | |
| Abdominal pain (%) | 17 (43) (n = 40) | 22 (35) | 0.5 | |
| Nausea (%) | 18 (45) (n = 40) | 39 (62) | 0.09 | |
| Vomiting (%) | 11 (28) (n = 40) | 25 (40) | 0.3 | |
| Diarrhea (%) | 7 (18) (n = 40) | 22 (35) | 0.07 | |
| Cough (%) | 14 (35) (n = 40) | 24 (38) | 0.8 | |
| Sputum (%) | 8 (20) (n = 40) | 13 (21) | 1.0 | |
| Dyspnea (%) | 5 (13) (n = 40) | 7 (11) | 1.0 | |
| Chest pain (%) | 3 (8) (n = 40) | 13 (21) | 0.1 | |
| Back pain (%) | 15 (38) (n = 40) | 19 (30) | 0.5 | |
| Dysuria (%) | 3 (8) (n = 40) | 2 (3) | 0.4 | |
| Arthralgia (%) | 10 (25) (n = 40) | 13 (21) (n = 62) | 0.6 | |
| Myalgia (%) | 34 (85) (n = 40) | 59 (95) (n = 62) | 0.1 | |
| Sore throat (%) | 3 (8) (n = 40) | 12 (19) | 0.2 | |
| Lymphadenopathy (%) | 1 (3) (n = 38) | 27 (46) (n = 59) | <0.001 | |
| Bleeding (%) | 2 (5) (n = 39) | 4 (6) (n = 58) | 1.0 | |
| Convulsions (%) | 0 (n = 40) | 1 (2) (n = 62) | 1.0 | |
| Rash (%) | 5 (13) (n = 38) | 16 (27) (n = 59) | 0.1 | |
| Abnormal chest exam (%) | 1 (3) (n = 38) | 16 (27) (n = 59) | 0.002 | |
| Abdominal tenderness (%) | 1 (3) (n = 39) | 6 (10) (n = 59) | 0.2 | |
| Liver palpable (%) | 27 (73) (n = 37) | 30 (52) (n = 58) | 0.05 | |
| Spleen palpable (%) | 6 (15) (n = 39) | 9 (15) (n = 59) | 1.0 | |
| Temperature (°C)‡ | 38.5 (38.2–38.8) (n = 36) | 38.6 (38.4–38.9) (n = 56) | 0.3 | |
| Pulse/min§ | 91.1 (87.1–95.1) (n = 36) | 95.7 (91.8–99.6) (n = 54) | 0.09 | |
| Systolic blood pressure (mm Hg)‡ | 100 (80–130) (n = 36) | 100 (90–150) (n = 54) | 0.6 | |
| Diastolic blood pressure (mm Hg)‡ | 70 (50–80) (n = 36) | 65 (50–110) (n = 54) | 0.8 | |
| Respiratory rate/min§ | 20.7 (19.9–21.6) (n = 36) | 22.9 (22.0–23.8) (n = 58) | 0.0012 | |
| Glasgow Coma Score‡ | 15 (15) (n = 38) | 15 (7–15) (n = 59) | 0.3 | |
| Meningism (%) | 2 (5) (n = 39) | 7 (12) (n = 59) | 0.3 | |
| Hematocrit (%)‡ | 40 (13–48) (n = 35) | 40 (23–50) (n = 53) | 0.7 | |
| Leukocyte count (×109/L)‡ | 10.4 (3.1–38) (n = 37) | 11.8 (0.7–26.3) (n = 54) | 0.1 | 4.0–11.0 |
| Neutrophils (%)‡ | 68 (26-86) (n = 37) | 70 (0–93) (n = 54) | 0.2 | |
| Platelets (×109/L)§ | 190 (23–350) (n = 37) | 200 (192–208) (n = 49) | 0.4 | 150–400 |
| Serum creatinine (μmol/L)‡ | 106 (70–466) (n = 32) | 106 (70–783) (n = 53) | 0.7 | 53–123 |
| Serum AST (IU/L)‡ | 87 (32–789) (n = 31) | 86 (16–437) (n = 52) | 0.6 | 7–35 |
| Serum ALT (IU/L)‡ | 39 (20–234) (n = 31) | 48 (12–180) (n = 52) | 0.7 | 7–35 |
| Serum albumin (g/L)‡ | 38 (26–50) (n = 32) | 35 (22–49) (n = 53) | 0.2 | 35–50 |
| Serum creatinine kinase (IU/L)¶ | 113 (80–159) (n = 32) | 121 (70–210) (n = 53) | 0.8 | 24–190 |
| Serum alkaline phosphatase (IU/L)‡ | 156 (47–532) (n = 32) | 175 (55–745) (n = 53) | 0.5 | 120–290 |
| Serum direct bilirubin (μmol/L)‡ | 8.3 (1.7–60.4) (n = 32) | 8.3 (2.6–83.0) (n = 52) | 0.9 | 0.5–8.8 |
| Serum total bilirubin (μmol/L)‡ | 17.9 (7.7–109) (n = 32) | 18.4 (7.7–131) (n = 52) | 0.4 | 1.7–20 |
| No. patients serum total bilirubin >50 μmol/L (%) | 2 (6) (n = 32) | 4 (8) (n = 52) | 1.0 | |
| No. patients serum AST >105 IU/L (%) | 11 (36) (n = 31) | 18 (35) (n = 52) | 1.0 | |
| No. patients serum ALT >105 IU/L (%) | 6 (19) (n = 31) | 5 (10) (n = 52) | 0.3 | |
| Deaths (%) | 0 | 1 (1.5) |
*AST, aspartate aminotransferase; ALT, alanine aminotransferase; CI, confidence interval. †The available sample size is given in parentheses where the entire sample was not available for a given variable. ‡Median (range). §Mean (95% CI). ¶Geometric mean (95% CI).
Clinical features of patients with serologic evidence for acute spotted fever rickettsioses admitted to Mahosot Hospital*
| Patient no. | Age (y), sex | Occupation | Month of onset of illness | Clinical features | Home |
|---|---|---|---|---|---|
| 45 | 30, male | Construction worker | March | 18-day fever, myalgia, nausea, epistaxis, vomiting, abdominal pain, petechial rash on trunk and legs; liver and spleen not palpable; treated with ampicillin and gentamicin | Vientiane City |
| 72 | 35, female | Teacher | April | 13-day fever, chills, headache, nausea, myalgia, vomiting, conjunctival suffusion, dyspnea, 12-cm liver; treated with ofloxacin | Vientiane City |
| 86 | 25, male | Health worker | May | 11-day fever, headache, nausea, vomiting, abdominal pain, 10-cm liver | Vientiane City |
| 114 | 18, male | Student | June | 14-day fever, chill, headache, arthralgia, myalgia, rash developed 2 days after admission, 12-cm liver; treated with ofloxacin | Vientiane Province |
| 198 | 50, male | Government official | September | 24-day fever, headache, arthralgia, myalgia, vertigo, epistaxis, diarrhea; abdominal CT suggested hepatic carcinoma; no antimicrobial drug | Xieng Khuang Province |
| 237 | 64, male | Government official | September | 21-day fever, myalgia, arthralgia, abdominal pain, sore throat, cough, dyspnea; chest exam abnormal | Vientiane City |
| 290 | 24, female | Construction worker | March | 7-day fever, headache, vomiting, myalgia, unproductive cough, diarrhea; treated with doxycycline | Vientiane City |
| 362 | 23, female | Student | June | 10-day fever, myalgia, headache, conjunctival suffusion, 8-cm liver; treated with doxycycline | Vientiane City |
| 297 | 43, female | Housewife | March | 14-day fever, headache, jaundice, RUQ pain, myalgia, 8-cm hepatomegaly; abdominal CT suggested tumor of intrahepatic bile ducts (cholangiocarcinoma?); treated with ampicillin and gentamicin | Xieng Khuang Province |
| 55 | 34, female | Housewife | April | 7-day fever, chills, headache, myalgia, diarrhea, abdominal pain, nausea, vomiting, rash on arms and abdomen; treated with oral chloramphenicol | Vientiane Province |
| 239 | 46, male | Merchant | November | 6-day fever, headache, myalgia, arthralgia, nausea, abdominal pain, diarrhea, dyspnea, dry cough, and sore throat; treated with doxycycline | Vientiane City |
*CT, computed tomographic scan; RUQ, right upper quadrant.
Serologic results of patients with serologic evidence for acute spotted fever rickettsioses admitted to Mahosot Hospital
| Patient no. | Immunofluorescence results (IgG/IgM admission sample, IgG/IgM convalescent-phase sample)* | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| "AT1"‡ | |
| 45 | 0/0, 1:256/1:128 | 0/0, 1:1,024/1:128 | 0/0, 1:1,024/1:128 | 0/0, 1:256/1:256 | 0/0, 1:256/1:256 | 0/0, 0/1:256 | 0/0, 1:256/1:256 | |
| 72 | 1:64/1:32 |
| 1:64/1:32 | 1:128/1:32 | 0/0 | 0/0 | 0/0 | 0/0 |
| 86 | 0/0, 1:64/0 | 0/0, 1:64/0 | 0/0, 1:64/1:128 | 0/1:128, 0/1:128 | 0/0, 0/1:32 | 0/0, 0/1:32 | 1:128/0, 1:128/1:32 | |
| 114 | 1:128/1:64 |
| 1:128/1:64 | 1:256/1:512 | 0/1:32 | 0/0 | 0/0 | 0/0 |
| 198 | 0/0 |
| 0/0 | 0/1:32 | 0/0 | 1:128/0 | 1:64/0 | 1:256/0 |
| 237 | 1:128/0 |
| 1:128/0 | 1:256/1:32 | 0/0 | 0/1:32 | 0/1:32 | 0/1:64 |
| 290 | 0/1:32, 0/1:32 | 0/0, 0/0 | 0/0, 0/0 | 0/0, 0/0 | 0/0, 0/0 | 0/0, 0/0 | 0/1:32, 0/1:32 | |
| 362 | 0/0, 0/0 | 0/0, 0/0 | 0/0, 0/0 | 1:16/1:16, 1:16/1:32 | 0/0, 0/0 | 0/0, 0/0 | 0/0, 1:32/1:32 | |
| 297 | 0/0, 0/1:64 | 0/0, 0/1:64 | 0/0, 0/1:64 | 0/0, 0/1:64 | 0/0, 0/0 | 0/0, 0/1:64 | 0/0, 0/0 | |
| 55 | 0/0, 1:64/1:32 | 0/1:64, 1:64/1:128 | 0/0, 1:64/1:32 | 0/1:64, 1:64/1:128 | 0/0, 1:256/0 | 0/0, 1:64/0 | 0/0, 1:256/0 | |
| 239 | 0/0 | 0/0 | 0/0 | 0/0 | 1:64/0 | 1:64/1:32 |
| 1:64/1:32 |
*Titers in boldface indicate the pathogen considered to be responsible for the serologic response. †R. conorii subsp. indica. ‡Rickettsia "AT1" from Japan.